UNRAVELING THE LEGACY AND FUTURE OF HEPATITIS B DIAGNOSIS: CLINICAL IMPACT OF CONVENTIONAL MOLECULAR TESTS AND HBV-RNA TO MONITOR HEPATIC INFECTIONS
May 15, 2019
USA (United States of America)
Hepatitis B infections remain a significant global healthcare burden resulting in 887,000 deaths in 2015. Clinical laboratories can have a measurable impact in improving liver disease care while maximizing healthcare systems efficiencies through the application of high-quality diagnostic technologies. Abbott Laboratories legacy of innovation in hepatitis diagnostics spans decades and continues with the development of an automated assay for the detection of serum HBV pregenomic RNA (pgRNA).